XML 74 R62.htm IDEA: XBRL DOCUMENT v3.20.2
Equity (Details Textual)
 1 Months Ended 9 Months Ended 12 Months Ended
Oct. 13, 2020
USD ($)
shares
May 31, 2020
May 03, 2019
May 03, 2019
Mar. 12, 2019
Feb. 08, 2019
$ / shares
shares
Feb. 08, 2016
shares
Oct. 15, 2015
USD ($)
Aug. 31, 2019
USD ($)
Feb. 28, 2017
Oct. 02, 2016
Aug. 26, 2016
USD ($)
May 06, 2016
Mar. 31, 2016
Mar. 21, 2016
$ / shares
shares
Feb. 17, 2016
shares
Sep. 30, 2020
USD ($)
Investor
$ / shares
shares
Sep. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Mar. 12, 2020
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Mar. 28, 2018
$ / shares
shares
May 26, 2017
USD ($)
Equity (Textual)                                                
Common stock, authorized                             360,000,000   100,000,000         100,000,000    
Common stock, par value | $ / shares                             $ 0.001   $ 0.001         $ 0.001    
Due to related parties | $                                 $ 540,866         $ 425,689    
Common stock, shares issued                                 20,393,903         19,478,168    
Financial amendment, description       The Company filed a Certificate of Amendment with the Secretary of State of Nevada, which was effective May 8, 2019 upon its receipt of the written notice from Financial Industry Regulatory Authority ("FINRA"). Pursuant to the Certificate of Amendment, the Company effectuated a 1-for-18 reverse stock split of its issued and outstanding shares of common stock, $0.001 par value, whereby 318,485,252 outstanding shares of the Company's common stock were exchanged for 17,693,625 shares of the Company's Common Stock. All shares and related financial information in this Form 10-Q reflect this 1-for-18 reverse stock split.                                        
Agreement, description                   The Company remitted this amount to BioLite with $650,000 in cash and $5,850,000 in the form of newly issued shares of the Company's Common Stock, at the price of $2.0 per share, for an aggregate number of 2,925,000 shares. Upon the consummation of the restructuring transaction between the Company and BioLite on February 8, 2019, the Company's Common Stock held by BioLite Taiwan was accounted for treasury stocks in the statement of equity (deficit).   The Company issued 1,468,750 shares ("Shares") of the Company's Common Stock, par value $0.001 (the "Offering") to BioLite Taiwan pursuant to a certain Stock Purchase Agreement dated August 26, 2016 (the "SPA"). The Shares are exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), pursuant to Regulation S of the Securities Act promulgated thereunder. The purchase price per share of the Offering is $1.60. The net proceeds to the Company from the Offering are approximately $2,350,000. Pursuant to the BioLite Collaborative Agreement, BriVision should pay a total of $100,000,000 in cash or stock of the Company with equivalent value according to the milestone achieved. The agreement requires that 6.5% of total payment, $6,500,000 shall be made upon the first IND submission which was submitted in March 2016. The Company and BioLite Taiwan agreed to amend the BioLite Collaborative Agreement, through entry into the Milestone Payment Agreement, whereby the Company has agreed to issue shares of Common Stock of the Company, at the price of $1.60 per share, for an aggregate number of 562,500 shares, as part of the Company's first installation of payment pursuant to the Milestone Payment. The shares issuance was completed in June 2016.                      
Due to related parties consideration | $                 $ 4,872,340                              
Forward split ratio     The Company filed a certificate of amendment to the Company's articles of incorporation (the "Amendment") to effect the Reverse Split with the Secretary of State of Nevada. The Financial Industry Regulatory Authority ("FINRA") informed the Company that the Reverse Split was effective on May 8, 2019. All shares and related financial information in this Form 10-Q reflect this 1-for-18 reverse stock split.   i) effect a stock reverse split at the ratio of 1-for-18 (the "Reverse Split") of both the authorized common stock of the Company (the "Common Stock") and the issued and outstanding Common Stock and ii) to amend the articles of incorporation of the Company to reflect the Reverse Split. The Board approved and authorized the Reverse Split without obtaining approval of the Company's shareholders pursuant to Section 78.207 of Nevada Revised Statutes.                   1 to 3.141                  
Subscription receivable | $               $ 350,000                                
Private placement, description   The Company received capital contributions of $1,697,051 in cash from 42 investors through private placements of the sale of certain number of Common Stocks for the purchase price of $2.25 per share of Common Stock and a free warrant attaches with each Common stock that was purchased. As of June 30, 2020, the shares have not been issued and the Company recorded the advanced receipts as subscribed stock.                                            
Private Placement [Member]                                                
Equity (Textual)                                                
Capital contributions | $                                 $ 456,180              
Purchase price per share | $ / shares                                 $ 2.25              
Number of investors | Investor                                 5              
Note Holders [Member]                                                
Equity (Textual)                                                
Aggregated common shares                                 795,735              
Kimho Consultants Co., Ltd [Member]                                                
Equity (Textual)                                                
Common stock, par value | $ / shares                                             $ 1.60  
Common stock, shares issued                                             75,000  
Common stock, shares issued total                                             120,000  
2016 Equity Incentive Plan [Member]                                                
Equity (Textual)                                                
Common stock issued pre-stock split                               50,000                
Common stock issued post-stock split                               157,050                
Share Exchange Agreement [Member]                                                
Equity (Textual)                                                
Common stock issued pre-stock split             52,336,000                                  
Common stock issued post-stock split             164,387,376                                  
Share Exchange Agreement One [Member]                                                
Equity (Textual)                                                
Common stock issued pre-stock split             52,936,583                                  
Common stock issued post-stock split             166,273,921                                  
Share Exchange Agreement Two [Member]                                                
Equity (Textual)                                                
Common stock issued pre-stock split             51,945,225                                  
Common stock issued post-stock split             163,159,952                                  
Percentage of common shares issued and outstanding             79.70%                                  
Percentage of issued share capital             100.00%                                  
Share Exchange Agreement Three [Member]                                                
Equity (Textual)                                                
Common stock issued pre-stock split             52,936,583                                  
Common stock issued post-stock split             166,273,921                                  
Exchange ratio             0.2536-for-1                                  
Share Exchange Agreement Four [Member]                                                
Equity (Textual)                                                
Common stock issued pre-stock split             65,431,144                                  
Common stock issued post-stock split             205,519,223                                  
Collaborative Arrangement [Member]                                                
Equity (Textual)                                                
Issuance of common shares | $                                 $ 3,000,000              
Issuance of common shares, shares                                 428,571              
Due to related parties | $                                 $ 100,000,000              
Consulting agreement, description                     The Company agreed to indemnify the consultant in an amount of $150 per hour in cash up to $3,000 per month, and issue to Kameyama the Company's Common Stock at $1.00 per share for any amount exceeding $3,000.                          
Collaborative Arrangement One [Member]                                                
Equity (Textual)                                                
Due to related parties | $                       $ 100,000,000                        
Percentage of payments under collaborative agreement                           6.50%                    
Euro-Asia Investment & Finance Corp Ltd. [Member]                                                
Equity (Textual)                                                
Common stock, par value | $ / shares                                             $ 1.60  
Common stock, shares issued                                             50,000  
Common stock, shares issued total                                             80,000  
Consulting Agreement [Member]                                                
Equity (Textual)                                                
Common stock, par value | $ / shares                                             $ 1.60  
Non-employee stock-based compensation | $                                     $ 28,800 $ 5,400        
Common stock, shares issued                                             4,828  
Common stock, shares issued total                                             7,725  
Co-Dev Agreement [Member]                                                
Equity (Textual)                                                
Due to related parties | $                                               $ 3,000,000
Euro-Asia Agreement [Member]                                                
Equity (Textual)                                                
Non-employee stock-based compensation | $                                     0 60,000        
Kimho Agreement [Member]                                                
Equity (Textual)                                                
Non-employee stock-based compensation | $                                     $ 0 $ 90,000        
BioKey [Member]                                                
Equity (Textual)                                                
Common stock issued post-stock split           1,642,291                                    
Issuance of common shares, shares           29,561,231                                    
Purchase price per share | $ / shares           $ 1.50                                    
BioLite [Member]                                                
Equity (Textual)                                                
Issuance of common shares, shares           74,997,546                                    
Officer One [Member]                                                
Equity (Textual)                                                
Common stock, par value | $ / shares                                             $ 1.60  
Common stock, shares issued                                             50,000  
Common stock, shares issued total                                             80,000  
Officer Two [Member]                                                
Equity (Textual)                                                
Common stock, par value | $ / shares                                             $ 1.60  
Common stock, shares issued                                             50,000  
Common stock, shares issued total                                             80,000  
Officer Three [Member]                                                
Equity (Textual)                                                
Common stock, par value | $ / shares                                             $ 1.60  
Common stock, shares issued                                             50,000  
Common stock, shares issued total                                             80,000  
Kameyama [Member]                                                
Equity (Textual)                                                
Issuance of common shares, shares 24,694                                              
Unpaid salary amount | $ $ 49,388                                              
Articles of Incorporation [Member]                                                
Equity (Textual)                                                
Common stock, par value | $ / shares                                         $ 0.001      
Articles of Incorporation [Member] | Maximum [Member]                                                
Equity (Textual)                                                
Common stock, authorized                                         100,000,000      
Articles of Incorporation [Member] | Minimum [Member]                                                
Equity (Textual)                                                
Common stock, authorized                                         20,000,000      
View Trade Securities Inc [Member]                                                
Equity (Textual)                                                
Consulting fees | $                                   $ 135,000            
Placement agent agreement, description                                   The agreement, the Company agreed to pay View Trade 60,000 restricted common shares of the Company and 60,000 warrants to purchase common shares of the Company at an exercise price of $6 per share for a period of 5 years with cashless exercise provision.            
Consulting Agreement [Member]                                                
Equity (Textual)                                                
Purchase price per share | $ / shares                                 $ 2.9              
Aggregated common shares                                 50,000              
Non Related Parties [Member]                                                
Equity (Textual)                                                
Debt conversion, description                                 a. Keypoint converted the aggregated amount of $292,826 at the conversion price of $1.84 on April 5, 2020, in exchange for 159,145 shares of the Company’s common stock, and warrants to purchase 159,145 shares of the Company’s common stock.